NDC 63323-881
Sodium Phosphates
Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous
Sodium Phosphates is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Fresenius Kabi Usa, Llc. The primary component is Sodium Phosphate, Dibasic, Anhydrous; Sodium Phosphate, Monobasic, Monohydrate.
Product ID | 63323-881_3ae3c9a3-3503-4264-8c77-00089f50cc74 |
NDC | 63323-881 |
Product Type | Human Prescription Drug |
Proprietary Name | Sodium Phosphates |
Generic Name | Sodium Phosphate, Monobasic, Monohydrate And Sodium Phosphate, Dibasic, Anhydrous |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS |
Marketing Start Date | 2022-03-30 |
Marketing Category | ANDA / |
Application Number | ANDA209997 |
Labeler Name | Fresenius Kabi USA, LLC |
Substance Name | SODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE |
Active Ingredient Strength | 142 mg/mL; mg/mL |
Pharm Classes | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |